Medical Office Europe

Collection of information with respect to COVID-19

Abiomed is committed to facilitate information exchange among HCP’s across the globe to exchange experiences. Please find here information for HCPs who are or might get in the research about COVID-19. Contrary to initial estimates, the virus is far more aggressive than expected and more than 100,000 patients died as a result of a COVID-19 infection. Although the exact connection has not yet been clarified, it appears to be a more pronounced virus interaction with the cardiovascular system. This does explain on the one side why elderly patients with CV – comorbidities have a critical risk for a fatal outcome. It is not clear whether there is an impact on younger patients with subclinical infection in the sense of delayed myocarditis or heart failure. COVID-19 obviously does use the angiotensin-converting enzyme 2 protein for cell entry.

Summary points of joint scientific meeting between ACC & CCC.

Download PDF

Collection of most recent Abiomed information on COVID-19.

Link to BOX

If you do have any additional question or comments please contact us via email.

Contact us via email